{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:00:06Z","timestamp":1768276806372,"version":"3.49.0"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"vor","delay-in-days":4193,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Toxicology"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>PNU\u2010200577 (labcode DD 01 [(R)\u2010N,N\u2010diisopropyl\u20103\u2010(2\u2010hydroxy\u20105\u2010hydroxymethylphenyl)\u20103\u2010phenylpropanamine) is a major pharmacologically active metabolite of tolterodine, a new muscarinic receptor antagonist intended for the treatment of an overactive bladder.<jats:italic>In virro<\/jats:italic>, PNU\u2010200577 produced a competitive and concentration\u2010dependent inhibition of carbachol\u2010induced contraction of guinea\u2010pig isolated urinary bladder strips (K<jats:sub>B<\/jats:sub>=0.84 nM; pA<jats:sub>2<\/jats:sub>=9. 14).<jats:italic>In vivo<\/jats:italic>, PNU\u2010200577 was significantly more potent at inhibiting acetylcholine\u2010induced urinary bladder contraction than electrically induced salivation in the anaesthetised cat (ID<jats:sub>50<\/jats:sub>15 and 40 nmol. kg<jats:sup>\u2212l<\/jats:sup>, respectively; P&lt;0.0l). In radioligand binding studies carried out in homogenates of guinea\u2010pig tissues and Chinese hamster ovary cell lines expressing human muscarinic ml\u2010m5 receptors, PNU\u2010200577 was not selective for any muscarinic receptor subtype. Thus, PNU\u2010200577 is similar to tolterodine in terms of antimuscarinic potency, functional selectivity for the urinary bladder<jats:italic>in vivo<\/jats:italic>and absence of selectivity for muscarinic receptor subtypes<jats:italic>in vitro<\/jats:italic>. The results of this study clearly indicate that PNU\u2010200577 contributes to the therapeutic action of tolterodine, in view of its high antimuscarinlc potency, similar serum concentration and lower degree of protein binding.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1997.tb02064.x","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T19:07:13Z","timestamp":1238008033000},"page":"169-172","source":"Crossref","is-referenced-by-count":78,"title":["Antimuscarinic Potency and Bladder Selectivity of PNU\u2010200577, a Major Metabolite of Tolterodine"],"prefix":"10.1111","volume":"81","author":[{"given":"Lisbeth","family":"Nilvebrant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per\u2010G\u00f6ran","family":"Gillberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Sparf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198835040-00006"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(25)00442-9","article-title":"The pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Andersson K.\u2010E.","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_1_4_1","unstructured":"Andersson S. H. G. A.Lindgren&P.\u2010O.Edlund:Metabolism of tolterodine in rat mouse dog and man. 4th International Society Study of Xenobiotics Meeting. Seattle August 27\u2010\u201031 1995."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(93)90027-B"},{"key":"e_1_2_1_6_1","first-page":"435","article-title":"Tolterodine \u2010\u2010\u2010 a new agent with tissue effect selectivity for urinary bladder","volume":"13","author":"Gillberg P.\u2010G.","year":"1994","journal-title":"Neurourol. Urodyn."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.30.040190.003221"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(75)90564-1"},{"key":"e_1_2_1_9_1","first-page":"524","article-title":"Effect of tolterodine on electrically induced contractions of isolated human detrusor muscle from stable and unstable bladders","volume":"14","author":"Naerger H.","year":"1995","journal-title":"Neurourol. Urodvn."},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1986.tb03647.x","article-title":"On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors","volume":"59","author":"Nilvebrant L.","year":"1986","journal-title":"Acta Pharmacol. et toxicol."},{"issue":"72","key":"e_1_2_1_11_1","first-page":"69","article-title":"Muscarinic receptor binding in the guinea pig parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum","volume":"17","author":"Nilvebrant L.","year":"1982","journal-title":"Scand. J. Gastroenterol."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1983.tb03427.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1983.tb01072.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90697-7"},{"key":"e_1_2_1_15_1","first-page":"433","article-title":"The in vitro pharmacological profile of tolterodine \u2010\u2010\u2010 a new agent for the treatment of urinary urge incontinence","volume":"13","author":"Nilvebrant L.","year":"1994","journal-title":"Neurourol. Urodyn."},{"key":"e_1_2_1_16_1","first-page":"523","article-title":"Interaction of tolterodine with cholinergic muscarinic receptors in human detrusor","volume":"14","author":"Nilvebrant L.","year":"1995","journal-title":"Neurourol. Urodyn."},{"key":"e_1_2_1_17_1","first-page":"310","article-title":"Tolterodine is not subtype (ml\u2010m5) selective but exhibits functional bladder selectivity in vivo","volume":"15","author":"Nilvebrant L.","year":"1996","journal-title":"Neurourol Urodyn."},{"key":"e_1_2_1_18_1","unstructured":"Postlind H. A.Lindgren&S. H. G.Andersson:Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of tolterodine. XIth International Symposium on Microsomes and Drug Oxidation. Los Angeles Jul 21\u2010\u201024 1996."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1949.tb00548.x"},{"key":"e_1_2_1_20_1","first-page":"43","volume-title":"Urodynamics: principles, practice and application","author":"Wein A. J.","year":"1994"}],"container-title":["Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1997.tb02064.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1997.tb02064.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T17:39:41Z","timestamp":1739036381000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1997.tb02064.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1600-0773.1997.tb02064.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1997.tb02064.x","archive":["Portico"],"relation":{},"ISSN":["0901-9928"],"issn-type":[{"value":"0901-9928","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}